- Association between genetic polymorphisms of the cytochromes P-450 (1A1, 2D6, and 2E1) and the susceptibility to pancreatic cancer
-
Lee HC, Yoon YB, Kim CY
- KMID: 1051581
- Korean J Intern Med.
- 1997 Jun;12(2):128-136.
OBJECTIVES: Metabolic activation is a prerequisite for the carcinogenic effect of many carcinogens, and considerable interindividual variation exists in the metabolic capacity to activate the carcinogens. The cytochromes P-450 (CYPs)... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines
-
Kim S, Yun YM, Chae HJ, Cho HJ, Ji M, Kim IS, Wee KA, Lee W, Song SH, Woo HI, Lee SY, Chun S
- KMID: 2373642
- Ann Lab Med.
- 2017 Mar;37(2):180-193.
- doi: 10.3343/alm.2017.37.2.180
Pharmacogenetic testing for clinical applications is steadily increasing. Correct and adequate use of pharmacogenetic tests is important to reduce unnecessary medical costs and adverse patient outcomes. This document contains recommended... -
- CITED
-
- Close
- SHARE
-
- Close
- Nonresponders to Daily Paroxetine and Another SSRI in Men With Lifelong Premature Ejaculation: A Pharmacokinetic Dose-Escalation Study for a Rare Phenomenon
-
Janssen PK, Touw D, Schweitzer DH, Waldinger
- KMID: 2069778
- Korean J Urol.
- 2014 Sep;55(9):599-607.
- doi: 10.4111/kju.2014.55.9.599
PURPOSE: Nonresponse to any selective serotonin reuptake inhibitor (SSRI) treatment is rare. In this study, we aimed to investigate ejaculation delay nonresponse to paroxetine treatment in men with lifelong premature... -
- CITED
-
- Close
- SHARE
-
- Close
